iBio, Inc.
IBIO
Last
$0.87
Day
-5.4%
1y
+7.7%
5y
-99.8%
52w
-75.9%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1132d
EMA 21
1.14
EMA 50
1.27
EMA 200
1.58
20d high
-32.8%
5y high
-99.8%
5y range
0th
Positions held
Your positionsIBIO isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-27
Hold
avoid
Signal
Strong Sell
Target
$1.08
Stop
$0.79
Stop distance
9.2%
Target vs last
+24.1%
Fundamentals
| Market cap | $59.16M | Enterprise value | -$26.68M | Trailing P/E | — | Forward P/E | -1.50 |
| PEG | — | Price / book | 0.60 | Beta | 1.26 | Dividend yield | 0.00% |
| Revenue growth | -100.0% | Earnings growth | — | Gross margin | 100.0% | Operating margin | -301.4% |
| Profit margin | 0.0% | ROE | -65.7% | ROA | -30.8% | Debt / equity | 0.03 |
| Current ratio | 7.85 | Free cash flow | -$13.62M | Analyst recommendation | strong_buy | Mean target | $5.69 |
| 52w high | $3.82 | 52w low | $0.78 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.1M | $0.2M | — |
| Op margin | — | — | — | -5951.0% | -2599.0% | — |
| Net income | -$10.6M | -$7.7M | -$9.0M | -$5.7M | -$5.2M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$6.4M | -$8.4M | -$9.4M | -$6.0M | -$5.2M | — |
- Operating margin compressed to -5951%.
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $0.1M | $0.4M | $0.2M | $0.0M | — |
| Op margin | -30138.0% | -4650.5% | -7392.9% | — | — |
| Net income | -$33.0M | -$18.4M | -$24.9M | -$65.0M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | $2.2M |
| Operating income | -$30.1M | -$18.6M | -$16.6M | -$29.3M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsIBIO · daily-30.8% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin